http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2537146-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61b58b6690d9688f8fb95ce90d8caeda
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
filingDate 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70cc0e8c71c9edb548bc21bbd50b3c3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6239c0ba09b40fa51c175d0b042712d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73dd6a690fcd108c1b76d46858742e8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20173cb0e879ecbab9baf31c73a56fb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e81106e9a300d2e93f3fcf1de25eaf3
publicationDate 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2537146-C1
titleOfInvention Agent for treating and preventing endometritis in animals
abstract FIELD: medicine. n SUBSTANCE: invention refers to veterinary science, particularly to an agent for treating and preventing endometritis in animals. The substance of the invention consists as follows. Novocaine 0.5 g is dissolved in distilled water 1 l, and the following preparations are dissolved in a solution of Novocaine 250 mg: powdered metronidazole 4.0 g is dissolved in Novocaine 250 ml; powdered ciprofloxacin 2.0 g is dissolved in Novocaine 250 ml; powdered Doxycycline 1.0 g is dissolved in Novocaine 250 ml; powdered tavegil 2.5 g is dissolved in Novocaine 250 ml; all the ingredients are combined to prepare the agent in an amount of 1 litre for treating and preventing endometritis in animals. n EFFECT: invention provides the pronounced anti-inflammatory and antimicrobial effect of a broad spectrum of action combined with reducing the body response to histamine, relieving smooth muscle spasm and reducing capillary penetration. n 5 tbl, 6 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2744919-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578464-C1
priorityDate 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2432945-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2367416-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2142804-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID29565
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454031468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54684461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449846626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID29565

Total number of triples: 46.